IndiaCOVID-19Ministry of Health and Family WelfareHealth

COVID – 19 Vaccination Update – Day 383

India’s cumulative vaccination coverage crosses 167.80 crore. More than 48 lakh Vaccine doses administered today till 7 pm

India’s COVID-19 vaccination coverage has crossed 167.80 Crore (167,80,54,625) today. More than 48 lakh (48,73,824) Vaccine Doses have been administered till 7 pm today. More than 1.34 Crore (1,34,51,315) Precaution Doses for the identified categories of beneficiaries for COVID vaccination have been administered so far. The daily vaccination tally is expected to increase with the compilation of the final reports for the day by late tonight.

The cumulative coverage of vaccine doses, segregated based on population priority groups, is as follows:

Cumulative Vaccine Dose Coverage
HCWs 1st Dose 10396559
2nd Dose 9885395
Precaution Dose 3505301
FLWs 1st Dose 18398483
2nd Dose 17278196
Precaution Dose 4277326
Age Group 15-18 years 1st Dose 47692349
  2nd Dose 2093497
Age Group 18-44 years 1st Dose 542695642
2nd Dose 410225658
Age Group 45-59 years 1st Dose 200598123
2nd Dose 172656761
Over 60 years 1st Dose 125103046
2nd Dose 107579601
Precaution Dose 5668688
Cumulative 1st dose administered 944884202
Cumulative 2nd dose administered 719719108
Precaution Dose 13451315
Total 1678054625

 

Today’s achievement in the vaccination exercise, segregated by population priority groups, is as follows:

Date: 2nd February, 2022 (383rd Day)
HCWs 1st Dose 270
2nd Dose 5573
Precaution Dose 51721
FLWs 1st Dose 695
2nd Dose 12815
Precaution Dose 131806
Age Group 15-18 years 1st Dose 432647
  2nd Dose 943753
Age Group 18-44 years 1st Dose 589463
2nd Dose 1660499
Age Group 45-59 years 1st Dose 104233
2nd Dose 391220
Over 60 years 1st Dose 71901
2nd Dose 240287
Precaution Dose 236941
Cumulative 1st dose administered 1199209
Cumulative 2nd dose administered 3254147
Precaution Dose 420468
Total 4873824

 

The vaccination exercise as a tool to protect the most vulnerable population groups in the country from COVID-19 continues to be regularly reviewed and monitored at the highest level.

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Comment moderation is enabled. Your comment may take some time to appear.

Back to top button